The DermaSensor Device vs the Dermatologist and the Pathologist: Lead Author Details New Study
Dermatologists at high volume dermatology centers referred suspicious lesions to pathology for biopsy and diagnosis. The results were compared with DermaSensor read-outs.
Knowledge Gaps in How to Manage Anaphylaxis, Epinephrine Use, Persist for Patients, Even EMS
ACAAI 2024. Two studies here showed that anaphylaxis protocols for EMS are outdated in many states and that many patients don't know how to use epinephrine.
Monotherapy with Rifaximin vs Lactulose More Effective for Reducing Recurrence of Overt Hepatic Encephalopathy: New Post Hoc Analysis
Rifaximin monotherapy may also confer a survival benefit, according to the study, which was awarded ACG Outstanding Research Award in the Liver Category.
A Melanoma Diagnosis is a 3-Part Process, Dermatologist Rebecca Hartman, MD, MPH, Explains
A rapid increase in the rate of melanoma diagnoses could be the result of multiple factors, explains the Harvard assistant professor of dermatology.
Semaglutide Linked with Reduced Risk of Alzheimer Disease in Large Observational Study
Semaglutide significantly reduced risk of a first-time diagnosis of AD in a cohort of more than 1 million, suggesting an opportunity for controlled clinical trials.
Primary Care Assessment of Suspicious Skin Lesions: A Dermatologist Highlights DermaSensor
A bothersome skin lesion is typically first seen and assessed in primary care. An AI-based point-of-care device may help enhance triage, says Rebecca Hartman, MD, MPH.
ACIP Supports Lowering Age for Pneumococcal Vaccination to 50 from 65 Years
The expanded recommendation includes shots from Merck (PCV21) and Pfizer (PCV20), and could be a "practice-changing milestone," one executive said.
Make Early Alzheimer Disease Medications Accessible to All, Now
FDA-approved early Alzheimer medications should be covered by Medicare and other insurers and made immediately available to all those who will benefit.
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions
Pfizer announced the FDA approval on October 22 that makes Abrysvo now the RSV immunization with the broadest indication for adults, the company said.
FDA Updates Flublok Label with Safety Data for Pregnant Individuals
The safety data used to update the Flublok label is from a study of more than 48 000 pregnant women across multiple flu seasons, according to Sanofi.
Why is Atopic Dermatitis Prevalence Rising? Dermatologist Mona Shahriari, MD, Parses the Trends
Shahriari, assistant clinical professor of dermatology at Yale University School of Medicine, says greater understanding of the condition has expanded the population for the diagnosis.
Exclusive Physician Survey Results on GLP-1 Receptor Agonists: The Hype Is Real
Three-quarters of primary care survey respondents prescribe GLP-1 RAs for weight loss and half get questions daily about the drugs. See all the results.
Vertex Presents Phase 3 Data on Nonopioid Suzetrigine to Treat Acute Pain at Anesthesiologists' Annual Meeting
The FDA has set a PDUFA date of January 30, 2025 for the investigational oral nonopioid therapy for acute pain, which could be a first-in-class win for Vertex.
Oral Semaglutide Shows 14% Reduction in MACE in Adults with T2D, ASCVD, and/or CKD: Topline Results from Phase 3 SOUL Trial
Novo Nordisk plans to file for regulatory approval this year of an expanded label for oral semaglutide, with an indication for reduction of MACE in high-risk adults with T2D.
Atopic Dermatitis is Not "Just" Eczema: Disease Primer with Mona Shahriari, MD
Dermatology thought leader Mona Shihriari, MD, offers a brief overview of the inflammatory skin disease for primary care clinicians.
IDWeek 2024: Novavax Reports Positive Data for Novel Influenza and Flu-COVID-19 Combination Vaccines
IDWeek2024: The nanoparticle influenza vaccine and combination flu-Covid-19 shot produced immunogenicity comparable to or higher than comparator vaccines.
7 Factors That Lead Americans to Skip Health Screening
Essential health screenings and immunizations are declining among US adults. A new survey identified 7 issues that help drive the reduced rates.
Breast Cancer Screening: Start Young and Stay With It
Women who receive a false positive breast cancer screening result may forego future mammograms. Thoughtfully counsel any young patient who may be feeling this way.
Elinzanetant Data from Bayer Feature Prominently at 19th World Congress on Menopause
Bayer announced 12 presentations focused on symptoms of menopause and effects of its investigational oral nonhormonal medication elinzanetant.
Effective Breast Cancer Prevention Requires A Primary Care Advocate, Expert Says
After a false positive breast cancer screening result, women may be reluctant to participate in future screening, a topic that could benefit from the primary care touch.
False Positive Breast Cancer Screening Linked with Greater Risk of Later Diagnosis
Even after adjusting for breast density, studies reveal a significantly greater risk for a cancer diagnosis within 2 decades. A UC Davis expert offers details.
Family Caregiving for Alzheimer Disease Worth a 6-Figure Annual Salary: New Research
Supported by Otsuka, new research calculated the value of daily hours spent on basic chores and complex tasks required to support a loved one with AD.
FDA Faces Law Suit Over Sudden Removal of Tirzepatide from Drug Shortage List
Update: The FDA has told compounding pharmacies they may resume production of tirzepatide products while the agency further investigates supply.
How Likely is a False Positive Breast Cancer Screening Result? Veteran Researcher Explains
A false positive finding on a screening mammogram is fairly common, according to UC Davis biostatistician Diana Miglioretti, PhD. Here's why.
Novel DHE Nasal Spray Safe, Effective For Acute Treatment of Migraine in Long-Term Safety Trial
Use of the unique STS101 drug device combination proved safe, well tolerated, and effective with as needed use over 12 months, reported Satsuma Pharmaceuticals.
After a False Positive Result, Screening Mammography May Not be a Priority for Some Women
The group of women least likely to return for a regular preventive screening mammogram after a false positive result surprised this primary investigator.
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.
Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date
The elinzanetant NDA is based on data, including long-term efficacy, from the OASIS phase 3 clinical trial program, according to Bayer.
Researcher Explains How Women Respond to a False Positive Breast Cancer Screening Result
After a false positive outcome on screening mammography, a short interval call back for repeat imaging was a significant deterrent to future screening.
Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data
CHEST 2024: Combined data from 4 continents found consistently better adherence/persistence when COPD triple therapy was initiated with a single inhaler.
